GV

GV

USD

Visionary Holdings Inc. Common Shares

$1.470+0.030 (2.083%)

실시간 가격

Consumer Defensive
Education & Training Services
캐나다

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.440

고가

$1.490

저가

$1.420

거래량

0.03M

기업 기본 정보

시가총액

6.0M

산업

Education & Training Services

국가

Canada

거래 통계

평균 거래량

1.91M

거래소

NCM

통화

USD

52주 범위

저가 $1.022현재가 $1.470고가 $9.6

관련 뉴스

PR Newswire

Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market

Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its ...

더 보기
Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market
PR Newswire

Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development

At 10:00 a.m. (Eastern Time, USA) on November 3, 2025, Visionary Holdings Inc. (hereinafter referred to as the "Company", NASDAQ: GV) successfully...

더 보기
Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development
PR Newswire

Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing

Visionary Holdings Inc. (Nasdaq: GV) ("Visionary" or the "Company"), a private education service provider integrating technology and innovation,...

더 보기
Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing
PR Newswire

Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity

Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced the...

더 보기
Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity